Third-party lab testing: 1 independent Janoshik assay on file, median measured purity 99.8%, most recent test 2024-09-30.
Peptide supplier identified through Janoshik analytical testing records.
GYC is listed as active. Discovered via Janoshik third-party lab testing.
| Substance | Measured purity | Test date |
|---|---|---|
| Tirzepatide 60mg{Transparent Red Cap} | 99.77% | 2024-09-30 |
| Status | Active |
|---|---|
| Independent assays on file | 1 |
| Median measured purity | 99.8% |
| Certificates of analysis | Vendor states COAs are available |
| Vendor type | Research-use supplier |
GYC is listed as active and we hold 1 independent Janoshik assay on file, median measured purity 99.8%. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. We hold 1 third-party Janoshik assay for GYC, with a median measured purity of 99.8%. The most recent is dated 2024-09-30.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Haikou Mingheng Biotechnology Peptides Review, Haikou Mingheng Technology Peptides Review, Hainan Flying International Trade Peptides Review.